Literature DB >> 7492542

Binding to protein targets of peptidic leads discovered by phage display: crystal structures of streptavidin-bound linear and cyclic peptide ligands containing the HPQ sequence.

B A Katz1.   

Abstract

The streptavidin-bound crystal structures of two disulfide-bridge cyclic peptides (cyclo-Ac-[CHPQGPPC]-NH2 and cyclo-Ac-[CHPQFC]-NH2) and of a linear peptide (FSHPQNT) were determined, as well as the structure of apostreptavidin (streptavidin-sulfate). Both the linear and disulfide-bridged cyclic peptides studied share a common HPQ conformation and make common interactions with streptavidin, although significant differences in structures and interactions occur for flanking residues among the complexes. The conformation of the linear peptide in the crystal structure of streptavidin-FSHPQNT was found to differ from that in the same complex published [Weber, P. C., Pantoliano, M. W., & Thompson, L. D. (1992) Biochemistry 31, 9350-9354]. In the present investigation, the HPQNT portion of the ligand is well-defined with some density defining the Phe, whereas in the investigation of Weber et al. only the HPQ segment of the bound peptide could be interpreted. Both bound cyclic peptides adopt a beta-turn involving an H-bond between the His main chain carbonyl and the main chain amide NH of the i+3 residue. In the streptavidin-bound cyclo-Ac-[CHPQFC]-NH2 structure, there is an additional H-bond, indicative of alpha-helix, between the main chain His carbonyl and the main chain C-terminal Cys amide NH group. Binding interactions for both cyclic and linear peptides include direct H-bonds, H-bonds mediated by tightly bound water molecules, and hydrophobic interactions. The above structures and that of streptavidin-biotin in the literature are compared and discussed in the context of structure-based ligand design.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7492542     DOI: 10.1021/bi00047a005

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  32 in total

1.  The use of mRNA display to select high-affinity protein-binding peptides.

Authors:  D S Wilson; A D Keefe; J W Szostak
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

2.  Streptavidin tetramerization and 2D crystallization: a mean-field approach.

Authors:  T Coussaert; A R Völkel; J Noolandi; A P Gast
Journal:  Biophys J       Date:  2001-04       Impact factor: 4.033

3.  Improved affinity of engineered streptavidin for the Strep-tag II peptide is due to a fixed open conformation of the lid-like loop at the binding site.

Authors:  Ingo P Korndörfer; Arne Skerra
Journal:  Protein Sci       Date:  2002-04       Impact factor: 6.725

4.  Plasticity in protein-peptide recognition: crystal structures of two different peptides bound to concanavalin A.

Authors:  D Jain; K J Kaur; D M Salunke
Journal:  Biophys J       Date:  2001-06       Impact factor: 4.033

5.  TEM-1 beta-lactamase as a scaffold for protein recognition and assay.

Authors:  Daniel Legendre; Bénédicte Vucic; Vincent Hougardy; Anne-Lise Girboux; Christophe Henrioul; Julien Van Haute; Patrice Soumillion; Jacques Fastrez
Journal:  Protein Sci       Date:  2002-06       Impact factor: 6.725

6.  Structural and biochemical characterization of linear dinucleotide analogues bound to the c-di-GMP-I aptamer.

Authors:  Kathryn D Smith; Sarah V Lipchock; Scott A Strobel
Journal:  Biochemistry       Date:  2011-12-27       Impact factor: 3.162

7.  Selection of cyclic-peptide inhibitors targeting Aurora kinase A: problems and solutions.

Authors:  Carolyn D Shomin; Elizabeth Restituyo; Kurt J Cox; Indraneel Ghosh
Journal:  Bioorg Med Chem       Date:  2011-09-29       Impact factor: 3.641

8.  Bacterial display using circularly permuted outer membrane protein OmpX yields high affinity peptide ligands.

Authors:  Jeffrey J Rice; Aaron Schohn; Paul H Bessette; Kevin T Boulware; Patrick S Daugherty
Journal:  Protein Sci       Date:  2006-04       Impact factor: 6.725

9.  Mimotopes of apical membrane antigen 1: Structures of phage-derived peptides recognized by the inhibitory monoclonal antibody 4G2dc1 and design of a more active analogue.

Authors:  Jennifer K Sabo; David W Keizer; Zhi-Ping Feng; Joanne L Casey; Kathy Parisi; Andrew M Coley; Michael Foley; Raymond S Norton
Journal:  Infect Immun       Date:  2006-10-23       Impact factor: 3.441

10.  Effect of fluorescently labeling protein probes on kinetics of protein-ligand reactions.

Authors:  Y S Sun; J P Landry; Y Y Fei; X D Zhu; J T Luo; X B Wang; K S Lam
Journal:  Langmuir       Date:  2008-12-02       Impact factor: 3.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.